Cargando…
Targeting immune co-stimulatory effects of PD-L1 and PD-L2 might represent an effective therapeutic strategy in stroke
Stroke outcome is worsened by the infiltration of inflammatory immune cells into ischemic brains. Our recent study demonstrated that PD-L1- and to a lesser extent PD-L2-deficient mice had smaller brain infarcts and fewer brain-infiltrating cells vs. wild-type (WT) mice, suggesting a pathogenic role...
Autores principales: | Bodhankar, Sheetal, Chen, Yingxin, Lapato, Andrew, Vandenbark, Arthur A., Murphy, Stephanie J., Offner, Halina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127946/ https://www.ncbi.nlm.nih.gov/pubmed/25157219 http://dx.doi.org/10.3389/fncel.2014.00228 |
Ejemplares similares
-
PD-L1 enhances CNS inflammation and infarct volume following experimental stroke in mice in opposition to PD-1
por: Bodhankar, Sheetal, et al.
Publicado: (2013) -
PD-L1 Amino Acid Position 88 Represents a Hotspot for PD-L1 Stability With Relevance for PD-L1 Inhibition
por: Claaß, Luise Victoria, et al.
Publicado: (2022) -
Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signaling
por: De Sousa Linhares, Annika, et al.
Publicado: (2019) -
Cross-Talk of the CNS With Immune Cells and Functions in Health and Disease
por: Matejuk, Agata, et al.
Publicado: (2021) -
Surviving the storm: Dealing with COVID-19
por: Vandenbark, Arthur A., et al.
Publicado: (2020)